Cardiac hypertrophy can be induced by treating ventricular myocytes with a wide variety of stimuli, ranging from GPCR agonists like endothelin-1 (ET1) and PE to receptor tyrosine kinase agonists such as epidermal growth factor (EGF). This evidence concerns the gene NTRK1 and cardiac hypertrophy.